-transparent.png){kind=logo}
Forty-nine patients with metastatic nonanaplastic thyroid carcinoma were treated over a 10-year period. Five successive chemotherapeutic protocols were used: a combination of doxorubicin, etoposide, 5-fluorouracil and cyclophosphamide; elliptinium acetate; doxorubicin; cisplatin; and the combination of doxorubicin and cisplatin. Results obtained with the different protocols were very disappointing, with only two objective responses (3%). Phase II trials with new chemotherapeutic agents are warranted in selected cases of nonanaplastic metastatic thyroid carcinoma.
Related Publications
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
November 1993,
Urology,
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
August 2006,
European journal of cancer (Oxford, England : 1990),
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
January 1987,
Acta oto-rhino-laryngologica Belgica,
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
January 1988,
Seminars in surgical oncology,
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
January 1993,
American journal of otolaryngology,
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
February 1998,
European journal of cancer (Oxford, England : 1990),
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
October 1952,
Concours medical,
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
February 1988,
European journal of cancer & clinical oncology,
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
September 1995,
Gynecologic oncology,
J P Droz, and
M Schlumberger, and
P Rougier, and
M Ghosn, and
P Gardet, and
C Parmentier
January 2004,
British journal of cancer,
